Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty. A Multicenter, Prospective, Non-controlled Post Market Clinical Follow-up Study

NCT03372278 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT03372278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03372278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty. A Multicenter, Prospective, Non-controlled Post Market Clinical Follow-up Study
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2013
Completion date
December 31, 2028
Enrollment
250 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis, congenital hip dysplasia, inflammatory arthritis, osteoarthritis, hip, post-traumatic; arthrosis, rheumatoid arthritis with adequate bone quality